Latest Breaking News On - Hany massarany - Page 1 : comparemela.com

ACCELERATE DIAGNOSTICS, INC : Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)

Item 3.03. Material Modification to Rights of Security Holders. On May 23, 2023, Accelerate Diagnostics, Inc. filed a Certificate of Amendment to the Certificate of Incorporation of the Company. | June 11, 2023

Mattheww strobeckJack schulerJohn patienceMarranh ogilvieWaynec burrisLouisel francesconiJack phillipsJenny reganHany massaranyCompany board of directors theCompany certificate of incorporationErnst youngSecurities exchangeDiagnostics incCompany current report on formRatification of independent registered public accounting firm

Accelerate Diagnostics (AXDX) announces appointment of Hany Massarany to Chairman of Board of Directors

Accelerate Diagnostics (AXDX) announces appointment of Hany Massarany to Chairman of Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jack phillipsMark millerHany massaranyJohn patienceDiagnostics incChief executive officerAccelerate diagnostics

Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors

/PRNewswire/ Accelerate Diagnostics, Inc. (NASDAQ: AXDX) a disruptor in bloodstream infection identification and susceptibility testing today announced the.

United statesJack phillipsMark millerHany massaranyJohn patienceRoche ltdDiagnostics incBiodesix incPrnewswire accelerate diagnostics incGenmark diagnostics incChief executive officerAccelerate diagnosticsGenmark diagnosticsVentana medical systemsRoche tissue diagnosticsChief operating officer

Accelerate Diagnostics, Inc (NASDAQ:AXDX) Expected to Announce Earnings of -$0 32 Per Share

Analysts predict that Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating) will announce earnings per share (EPS) of ($0.32) for the current quarter, according to Zacks. Two analysts have made estimates for Accelerate Diagnostics’ earnings. Accelerate Diagnostics posted earnings per share of ($0.41) in the same quarter last year, which would indicate a positive year-over-year growth […]

United statesThomson reuterHany massaranyCraig hallumWilliam blairZacks investment researchCapital partnersSg americas securitiesDiagnostics incBarclays plcCapital advisors incAccelerate diagnosticsGet ratingAccelerate diagnosticInvestment researchDirector hany massarany

Accelerate Diagnostics, Inc (NASDAQ:AXDX) Expected to Announce Quarterly Sales of $3 12 Million

Analysts predict that Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating) will announce $3.12 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Accelerate Diagnostics’ earnings, with the lowest sales estimate coming in at $2.90 million and the highest estimate coming in at $3.33 million. Accelerate Diagnostics […]

Jackw schulerHany massaranyCraig hallumWilliam blairDaiwa securities group incSquarepoint opsDiagnostics incZacks investment researchCitigroup incCapital advisors incAccelerate diagnosticsGet ratingAccelerate diagnosticInvestment researchDirector hany massaranyDirector jack